For peri- or post-menopausal women, including those with premature ovarian insufficiency (POI) or early menopause (with normal cognition or mild cognitive impairment [MCI]), does hormone-replacement therapy (HRT) use, compared to no HRT, affect the risk of cognitive decline and/or dementia, and does type, duration, or age at initiation influence risk? (2025)
Attributed to:
SPIN Dementia Network+, Sustainable Prevention, Innovation and Involvement for Dementia (SPIN-D)
funded by
ESRC
Abstract
No abstract provided
Bibliographic Information
Publication URI: https://www.crd.york.ac.uk/PROSPERO/view/CRD42025639384
Type: Other